HOMEwww.epgonline.orgDRUGSwww.epgonline.orgDISEASE KNOWLEDGEwww.epgonline.orgGUIDELINESwww.epgonline.orgCLINICAL TRIALSwww.epgonline.orgREGISTERwww.epgonline.orgSEARCH
Members
Why a doctor should
Username/Email

Password ()




EPG on Twitter EPG Online Twitter
EPG Online Blog EPG Online Blog
EPG Online Disease Knowledge Centres Feed Disease Knowledge
Recent UK Drug Updates Drug Updates
EPG Search
Search
Languages

Nystatin-Dome Suspension 100,000 I.U./ml overview
The prevention and treatment of candidal infections of the oral cavity, oesophagus and intestinal tract. The suspension provides effective prophylaxis against oral candidosis in those born of mothers with vaginal candidosis.
banner_pass = 1

Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.

Change language Current language database: English
 
 
Related DrugsDrug Details
Nystatin-Dome Suspension 100,000 I.U./ml
Drug Class Description :

Antifungals.

Generic Name :

nystatin

Drug description :

Each ml contains 100,000 I.U. Nystatin BP.

Presentation :

Oral suspension

Indications :

The prevention and treatment of candidal infections of the oral cavity, oesophagus and intestinal tract. The suspension provides effective prophylaxis against oral candidosis in those born of mothers with vaginal candidosis.

Adult Dosage :

For the treatment of denture sores, and oral infections in adults caused by candidas albicans. 1ml of the suspension should be dropped into the mouth four times daily; it should be kept in contact with the affected areas as long as possible.

For the treatment of intestinal candidosis 5ml of the suspension should be dropped into the mouth four times daily.

For prophylaxis a total daily dosage of 1 million units has been found to suppress the overgrowth of candidas albicans in patients receiving broad-spectrum antibiotic therapy.

Administration should be continued for 48 hours after clinical cure to prevent relapse.

Child Dosage :

In intestinal and oral candidosis (thrush) in infants and children 1ml should be dropped into the mouth four times a day. The longer the suspension is kept in contact with the affected area in the mouth before swallowing, the greater will be its effect.

Administration should be continued for 48 hours after clinical cure to prevent relapse.

For prophylaxis in the newborn the suggested dose is 1ml once daily.

Elderly Dosage :

No specific dosage recommendations or precautions.

Contra Indications :

Contra-indicated in patients with a history of hypersensitivity to any of the components.

Special Precautions :

Nystatin Oral Suspension BP contains sugar.

Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.

Nystatin oral preparations should not be used for treatment of systemic mycoses.

The label states the following warnings:-

Shake well before use.

Do use if seal is broken.

This product should not be diluted.

Store in a cool place. Avoid freezing.

Protected from light.

Interactions :

Not known.

Adverse Reactions :

Nystatin is generally well tolerated by all age groups, even during prolonged use. Rarely hypersensitivity, oral irritation or sensitisation may occur. Nausea has been reported occasionally during therapy.

There have been reports of rash (including urticaria) and rarely Stevens-Johnson syndrome has been reported.

Large doses of nystatin could cause face oedema, vomiting, diarrhoea and gastrointestinal distress.

Manufacturer :

Sandoz Limited

Drug Availability :

(POM)

Drug Updated :

15 February 2012

Related Drugs - Antifungals
Niemann-Pick Type C Chronic Kidney Disease (CKD) is characterised by a gradual and permanent loss of kidney function that worsens as it progresses from stages 1 to 5. One of the most common complications of CKD is anaemia. Opioid and Pain Management - understanding, management, diagnosis and treatment information Parkinson's disease (PD) is a degenerative disorder of the central nervous system characterized by the clinically asymmetric onset of resting tremor, bradykinesia, rigidity and postural instability.
New and updated Drugs
UK Drugs EPG Medical News Feed
Spanish Drugs EPG Medical News Feed
German Drugs EPG Medical News Feed
Norweigan Drugs EPG Medical News Feed
Netherlands Drugs EPG Medical News Feed
Swedish Drugs EPG Medical News Feed
French Drugs EPG French Drugs Feed
Portuguese Drugs EPG Portuguese Drugs Feed
Italian Drugs EPG Italian Drugs Feed

Atopic Dermatitis

Atopic Dermatitis

CONNECT

DISEASE CENTRES Disease Centres feed

AFFILIATE PARTNERS

QUICK SEARCH

GUIDELINES UK Drug Data Feed

DRUG DATA UK Drug Data Feed

REFERENCES